Vote Scores

Home / Companies / Infinity Pharmaceuticals, Inc. / 14 Jul 2023

Meeting · year to 30 June 202449 filers reporting

Infinity Pharmaceuticals, Inc.: meeting of 14 Jul 2023

Votes reported on Form N-PX, item by item

49 Form N-PX filers reported votes at the Infinity Pharmaceuticals, Inc. meeting of 14 Jul 2023. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on pay tied to a merger or sale

57 vote records from 48 filers. 4 of the 45 filers that marked the item either way voted against management. 3 filers reported this item without a management mark.

85.4% for8.3% against6.3% other8.9% against management48 filers
2

EXTRAORDINARY TRANSACTIONSIssuer

EXTRAORDINARY TRANSACTIONS: management items

Management items in this category are shown together; filers word and number them differently.

15 vote records from 11 filers. 0 of the 11 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management11 filers100.0% for0.0% against0.0% against management4,969,467 reported shares, counted once per item in this group
3

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

15 vote records from 11 filers. 1 of the 11 filers that marked the item either way voted against management.

90.9% for9.1% against9.1% against management11 filers84.9% for15.1% against15.1% against management4,969,467 reported shares, counted once per item in this group

How the largest families voted

Family1. Merger pay
VanguardFor
BlackRock and iSharesFor
FidelityFor
State Street and SPDRFor
Franklin TempletonFor
Nuveen and TIAAAgainst *
Goldman SachsFor
Northern Trust and FlexSharesAgainst *
Guggenheim and RydexFor
BNY MellonFor

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Infinity Pharmaceuticals, Inc. meeting?

49 Form N-PX filers reported votes at the meeting of 14 Jul 2023. The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Infinity Pharmaceuticals, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Infinity Pharmaceuticals, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Infinity Pharmaceuticals, Inc. with a meeting date within three days of 14 Jul 2023. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 30 Sep 2026.